Barbara Gayle Duncan
Director · 3 filings · Latest: Jun 18, 2026
Atea Pharmaceuticals, Inc.
HALOZYME THERAPEUTICS, INC.
Ovid Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVIR | Barbara Gayle Duncan | Director | Jun 18, 2026 | Option Exercise | $0.00 | 29,600 | — | 92,350 |